Tag Archives: Investment

Medcenter One, Sanford Health Merger Details Include $200 Million Investment in Western North Dakota


Bismarck, ND (PRWEB) July 14, 2012

Medcenter One and Sanford Health are stronger together. On July 2 they officially merged and Sanford Health now features more than 1,200 physicians and 25,000 employees in seven states.

Sanford Health will invest $ 200 million over the next 10 years to enhance health care services in Bismarck-Mandan and throughout western North Dakota, including a new super clinic in Dickinson, the gateway to the regions bustling oil fields. The clinic will feature all the current services provided in Dickinson along with space for additional physicians, a walk-in clinic, an ambulatory surgery center and diagnostic services.

The benefit for patients will be greater access to quality care, from primary to highly specialized care that is typically only available in large urban centers. Together the two promise to recruit more physicians, expand air transport and trauma services, provide the latest medical technology and innovations in care, and expand and upgrade services and facilities to meet the growing needs of people all across North Dakota.

?All along this journey the response has been incredibly positive. This merger takes the magic of momentum that was created by the 2009 merger of Sanford and MeritCare, and extends that momentum through the entire state of North Dakota, creating a new level of medical sophistication and impact on the ability to provide care?one life at a time,? said Kelby Krabbenhoft, president and CEO of Sanford Health.

Medcenter One will operate under the Sanford Health name. Bismarck-Mandan will become the epicenter of the new western region of Sanford Health, joining Sioux Falls, S.D., and Fargo as a regional center for the sprawling network of clinics and hospitals covering approximately 200,000 square miles in seven states, and now larger than North and South Dakota combined.

?This is a game changer for North Dakota health care,? said Craig Lambrecht, M.D., president and CEO of Sanford Bismarck. ?North Dakota is booming and Medcenter One is a strong partner well-positioned for growth. From 2006-2011 Medcenter One saw increases of 34 percent in emergency visits, 17 percent in births and 20 percent in clinic visits. In 2011 alone, Sanford Fargo saw a spike in hospital admissions of 9 percent. By coming together, we will be able to better meet the growing health care needs of our entire state.?

In March 2012, North Dakota surpassed Alaska in becoming the second leading state in crude oil production trailing only Texas. In 2005, there were 4,500 oil workers in the state; in 2012, there are more than 35,000. In 2011 North Dakota?s economy outpaced every other state with the fastest growth in personal income, jobs and home prices. Opportunity abounds in North Dakota, well beyond the oil fields. Together, the two systems will work aggressively to better care for growing patient population.

?When the Board looked at the merger, we saw nothing but positives for our patients,? said Pat Durick, chairman of the Medcenter One Board of Directors. ?The work Sanford Health is doing bringing cutting-edge research and highly specialized care to rural areas and its commitment to the communities it serves truly is changing health care for the better. We are excited to be a part of those efforts.?

Medcenter One and Sanford face similar challenges. Both serve geographic areas that are sparsely populated. Merging provides the population base for operational efficiencies and growth opportunities needed in order to support the advanced care patients depend on. Size helps to bear financial risks, gain access to capital, improve purchasing power, actively manage the delivery of care, invest in high-impact technologies as well as increase participation in research and development. Since the 2009 Sanford-MeritCare merger, savings of $ 19.6 million in supplies and services has been achieved. Integrated health systems are proven leaders in safe, high-quality care that is cost-effective. A combined organization is a means to ensuring that people all across the state of North Dakota continue to have access to high quality health care close to home.

About Medcenter One

Medcenter One is a non-profit, integrated health system headquartered in Bismarck-Mandan North Dakota with clinic locations in Bismarck, Dickinson, Jamestown, Mandan and Minot. Medcenter One consists of a 228-bed hospital, four multi-specialty clinics, a college of nursing, seven primary care clinics, four walk-in clinics, three kidney dialysis centers, three occupational health clinics, four long-term care facilities and a comprehensive group of health services in western and central North Dakota. Key accreditations and quality awards include: Joint Commission, American College of Surgeons Level II Emergency and Trauma Center and Magnet Recognition Program?.

About Sanford Health

Sanford Health is an integrated health system headquartered in Fargo, ND and Sioux Falls, SD and consists of two long-standing organizations that merged in 2009. Sanford is now the largest, rural, not-for-profit health care system in the nation with locations in 112 communities in seven states. In addition, Sanford Health is in the process of developing international clinics in Ireland, Ghana, Israel and Mexico.

Sanford Health includes 34 hospitals, 116 clinic locations and more than 1,000 physicians in 70 specialty areas of medicine. With more than 20,000 employees, Sanford Health is the largest employer in North and South Dakota. The system is experiencing dynamic growth and development in conjunction with Denny Sanford’s $ 400 million gift in 2007, the largest gift ever to a health care organization in America. This gift is making possible the implementation of the several initiatives including global children’s clinics, multiple research centers, eradicating breast cancer and finding a cure for type 1 diabetes. For more information, visit sanfordhealth.org.







More Cancer Press Releases

Open-Ended Investment Company Activities in the UK Industry Market Research Report Now Updated by IBISWorld


London, United Kingdom (PRWEB) June 22, 2012

Open-ended investment companies (OEICs) have weathered the financial storm well compared with their pooled investment peers. Partly attributable to asset selection and portfolio construction, revenue for OEICs is expected to decline at only an annualised 0.4% over the five years through 2012-13, to $ 51.4 billion. However, OEICs have been affected by the same systematic risk that caused the FTSE 100 to experience its largest decline in decades. The recent poor financial market performance has not deterred investments in OEICs. Fund sales suffered a minimal dip in 2007-08, but remained popular with investors despite risk appetites diminishing. Although most OEICs survived the financial crisis unscathed, several were forced to liquidate due to questionable asset selection. Several trends emerged even during the financial crisis. According to IBISWorld industry analyst Ee Jen Lee, ?although numerous investors were forced to withdraw from the financial markets entirely, other investors were shifting their wealth from risky equity securities to less risky fixed-income securities such as corporate and government bonds?.

However, persistent volatility has dampened revenue growth. The uncertainty permeating from Greece and other heavily indebted eurozone members has created waves of market speculation that have been detrimental to steady, stable market growth. Consequently, industry revenue is forecast to grow at a relatively subdued rate of 5.0% in 2012-13. OEICs can look forward to tapping into the growing institutional market over the next five years. Automatic enrolment in pension funds, which will be introduced from October 2012, is anticipated to affect nine million people. Lee adds, ?OEICs with a strong distribution network and a good track record of performance will be well placed to benefit from an expected surge in demand from institutional investors?. As such, industry revenue is forecast to grow strongly over the next five years to 2017-18.

The top four UK fund managers control an estimated 25.3% of industry FUM. According to the IMA, the top 10 fund management firms have an estimated 45% of industry UK-authorised funds. Consequently, revenue earned by the top four open-ended investment companies accounts for approximately 24.3% of industry revenue which equates to a low level of market share concentration for the industry. Major companies include Invesco, M&G Securities and Fidelity Investment Managers.

For more information on the Open-Ended Investment Company Activities industry, including latest industry trends, statistics, analysis and market share information, purchase the full report from IBISWorld, the nation?s largest publisher of industry research.

IBISWorld industry Report Key Topics

Open-ended investment companies (OEICs) are legal entities organised to pool securities or other financial assets, without managing, on behalf of shareholders or beneficiaries. The portfolios are customised to achieve specific investment characteristics, such as diversification, risk, rate of return and price volatility. OEICs are authorised by the Financial Services Authority under the Open-Ended Investment Companies (Companies with Variable Capital) Regulations.

Industry Performance

Executive Summary

Key External Drivers

Current Performance

Industry Outlook

Industry Life Cycle

Products & Markets

Supply Chain

Products & Services

Major Markets

Globalisation & Trade

Business Locations

Competitive Landscape

Market Share Concentration

Key Success Factors

Cost Structure Benchmarks

Barriers to Entry

Major Companies

Operating Conditions

Capital Intensity

Key Statistics

Industry Data

Annual Change

Key Ratios

About IBISWorld

Recognised as the nation?s most trusted independent source of industry and market research, IBISWorld offers a comprehensive database of unique information and analysis on many UK industries. With an extensive online portfolio, valued for its depth and scope, the company equips clients with the insight necessary to make better business decisions. Headquartered in London, IBISWorld serves a range of business, professional service and government organisations through more than 10 locations worldwide. For more information, visit http://www.ibisworld.co.uk or call (020) 3008 6568.







The Cottages Investment Group LLC Introduces Their Second Development Project , The Cottages Memory Care


Shawano, WI (PRWEB) May 09, 2012

The Cottages Investment Group LLC introduces their second development project , The Cottages Memory Care, to break ground May 9, 2012, focusing on the growing population of those suffering from memory loss and forms of dementia. John Olson, of WM Development, has designed Shawano?s first assisted living facility focusing on memory care. Licensed as a Community Based Residential Facility (CBRF), the Cottages Memory Care will be located next to the Cottages first assisted living building, The Cottages on Golden Pond, 103 Madison Way in Shawano, WI. Although they will offer only 14 private rooms, the staffing will be the same as their 33 unit assisted living facility, assuring the residents of the Memory Care will have the specialized care and attention needed 24/7. The new business will bring 15-20 new jobs to Shawano County.

Although a diagnosis of a dementia, such as Alzheimer disease, is not a prerequisite to live there, The Cottages staff will be fully trained as Dementia Care Specialists under the direction of the Brandon Erkkila, Professional Education Coordinator with the Alzheimer’s Association Greater Wisconsin Chapter. Brandon has been instrumental in his encouragement for The Cottages to move forward with this new design and development. Brandon states in regards to The Cottages project, ?Shawano county has an estimated population of 1108 people with dementia over the age of 65. I am very excited to see this little seed of an idea grow into a beautiful and well run memory care facility. I?m also very confident once people see what you are offering it will take off. It will be a nice breath of fresh air for the community.?

The Cottages Memory Care assisted living will be a secured building to emphasize freedom with no need for wanderguard bracelets or anklets. Dignity and excellence of care will be priority, as has already been demonstrated in the Cottages Investment Group?s first venture, The Cottages on Golden Pond Residential Care Apartment Complex, also located in Shawano. Cara Peterson, General Manager of The Cottages Investment Group, is responsible for start up and ongoing operations of both facilities. “Our staff take pride in the reputation they have built for The Cottages of Shawano. We all do this for one reason. To make life healthier and better for the elderly and their families in our community. Our Tenants and their children trust us to provide the best care possible. And we do a very good job at that.”

“Expanding our business to include a home environment for those with memory loss, gives us the opportunity to provide a much needed understanding of the care required for elderly, and their families, who live with this issue. One of our goals of bringing The Cottages Memory Care to this community is to provide not only specialized care for those with Alzheimer?s disease, but to educate families on how to come to terms with living in the world of memory loss. It cannot be cured, but we can learn to make that person?s life meaningful and add a touch of happiness. We want to help families find more meaningful moments when visiting by taking over the day to day caregiving responsibilities and health monitoring that sometimes can be overwhelming. I know we can do that, and do it very well.”

“Alzheimer?s has touched our families, like it has so many others, and it makes this project even more important. I am very proud to expand into this area of healthcare for Shawano County. Working closely with the area chapter of The Alzheimer?s Association will keep us on the forefront of new treatments and techniques in serving our residents and their families.?

The Cottages Memory Care can admit anyone 55 and older with a need for assisted living, but primary focus is on those with memory loss, whether it be from a stroke or disease, or diagnosed with a dementia such as Alzheimer?s Disease. The Cottages will also be able to assist families with short term stay rehab for strengthening or continued therapy following a hospital or nursing home stay. All care and medication management is supervised and directed by licensed professionals. In – house therapy and hospice services will be offered through local home health and hospice companies of the resident or families choosing.

Construction of the new building is scheduled for completion in September. Prior to opening, information on The Cottages Memory Care facility available by calling 866-477-3838, visiting on-site at 103 Madison Way, Shawano WI or http://www.thecottagesongoldenpond.com. The building will consist of 14 private rooms with private full bathrooms. 12 units remain and can be reserved starting on May 9, 2012 by contacting Cara Peterson at the phone number above or via email at carap(at)thecottagesshawano(dot)com .







Find More Alzheimers Press Releases

Increasing Investment in Stem Cell Technology and Promising Research Outcomes Drives the Stem Cell Research Market, According to New Report by Global Industry Analysts

San Jose, California (PRWEB) May 10, 2012

Follow us on LinkedIn ? Stem cell research is a promising area of biotechnology, which holds tremendous potential in rendering a new approach to the treatment of various degenerative diseases. The area deals with employing regenerative stem cells for the replenishment of damaged cells of a particular organ or tissue with new cells. These repair blocks have created a new specialty in the area of medicine called the regenerative medicine. Stem cells hold potential to treat conditions such as Alzheimer?s disease, Parkinson?s disease, stroke, spinal cord injury, heart disease, diabetes, burns, rheumatoid arthritis and osteoarthritis. In addition to its therapeutic applications, stem cells are also finding use in drug discovery, promising new avenues in the area of drug development. Growth in the research space is attributed to the acceptance of stem cell technology by patients for treating chronic diseases. Moreover advancement in stem cell research can help reduce the escalating healthcare costs associated with conventional methods of treatment.

Stem cell technology is still in a nascent stage. The market still lacks substantial data that could establish its long-term efficacy as well as safety. Certain issues pertaining to its administration have also raised concerns. The regulatory and ethical barriers across the world, particularly in Western countries, are the major challenges ahead of stem cells research. The barriers are particularly more in embryonic stem cell research. On the other hand, countries such as India, with comparatively less opposition, are better positioned to conduct stem cell research. Lack of proper funding is also a matter of concern for stem cell research. Countries, such as Thailand, Taiwan, Malaysia, Singapore, China, and India, are engaged in commercial, clinical, and scientific advancements in stem cell research without proper funding.

Over the past few years, the stem cells market has witnessed several breakthroughs that bodes tremendous potential in reshaping the area of medicine. Potential therapeutic applications of stem cells cut across several debilitating and deadly disease areas, including cancer and AIDS. Stem cell research is entering new avenues of medicine, and promises to provide a solution to combat diseases that were hitherto believed to be incurable. There is a growing demand for such therapies, which in turn provokes continued investments in the area, and foretell a remarkable growth in the industry in the coming years. Presently, the field is focused upon the treatment of certain oncological ailments, which include non-Hodgkin’s lymphoma, multiple myeloma, and leukaemia. Additionally, non-cancerous diseases, including lupus, immunodeficiency, and aplastic anaemia, are also being investigated for treatment using stem cell technology.

Mesenchymal stem cells and hematopoietic stem cells, extracted from adult bone marrow, are the leading types of adult stem cells currently in demand in the area of medicine. Of these types, hematopoietic stem cells hold major share in disease management. The dominance of hematopoietic stem cells is in part due to the difficulty associated with the isolation of mesenchymal from the bone marrow owing to availability of cells in lower levels. The greatest strength of adult stem cells is the presence of genomic stability of a very high degree. Additionally, stem cell therapy does not necessitate pre-treatment or genetic modification that is required when dealing with embryonic stem cells.

The US represents the largest regional market worldwide, as stated by the new market research report on Stem Cell Research. Despite the 9-year ban, which ended in 2009, over federal funding for research in embryonic stem cells, North America is presently dominating the stem cell market. Key factors that have kept North American market on the top of the charts include advanced stem cell research infrastructure and facilities, and federal support for the research. Asia is emerging as the fastest growing regional market for stem cell research worldwide with countries such as Japan, China, Singapore, Korea, and Australia evolving as major hubs for stem cell research.

Major players profiled in the report include Advanced Cell Technology Inc., Athersys Inc., Cytori Therapeutics Inc., Genzyme Corporation, Geron Corporation, International Stem Cell Corporation, Mesoblast Ltd., Osiris Therapeutics Inc., StemCells Inc., ThermoGenesis Corp., among others.

The research report titled ?Stem Cell Research: A Global Strategic Business Report? announced by Global Industry Analysts, Inc., provides comprehensive market overview, trends & issues, regulatory overview, overview on therapies under development, recent industry activity and profiles of market players worldwide. The report analyzes global adult stem cell research market in terms of annual investments in value for the years 2008 through 2017, for major geographic markets, including the US, Europe and Rest of World.

For more details about this comprehensive market research report, please visit ?

http://www.strategyr.com/Stem_Cell_Research_Market_Report.asp

About Global Industry Analysts, Inc.

Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world’s largest and reputed market research firms.

Follow us on LinkedIn

Global Industry Analysts, Inc.

Telephone: 408-528-9966

Fax: 408-528-9977

Email: press(at)StrategyR(dot)com

Web Site: http://www.StrategyR.com/

###







For Investment Client Reporting, Marketing & Pitchbook Content – Varden Technologies and PAICR Announce a Webcast on Investment Communications Strategies and Operations


Boston, MA (PRWEB) April 12, 2012

Varden Technologies joins PAICR to offer a members-only webcast on April 26, 2012, entitled “A Survey & Discussion: How Responsive Is Your Investment External Communications Strategy and Why?”

The webcast will provide a peer-review synopsis of how operational and strategic models have progressed, across sampled investment communications teams, in response to specific advances in business systems.

PAICR is a non-profit association created for and facilitated by investment marketing and communications professionals. PAICR members number in the hundreds, representing investment firms throughout North America, the U.K., and Australia. Varden Technologies is a data integration and investment communications technologies firm, focused on the production, governance, and publication of client reporting, data-driven pitchbook, and marketing content.

Preceding the webcast, a secure survey is active at InvestmentCommunications.org until 5:00pm EST on April 19, 2012. PAICR members are asked to participate by providing anonymous responses. Anonymous result sets will be serialized to form the basis for the webcast?s discussion on trends and practices. Varden will be leveraged to provide comparative views on where and why they have focused their technical designs and feature sets across their 90+ relationships. PAICR members will gain a post-webcast paper as the exercise?s end-deliverable for internal discussions.

Minh Nguyen, Varden?s Director, shares ?We?re happy to participate in this exercise. The intent is to survey how ops and strategies have been jolted by two industry progressions that finally have arrived to investment communications teams, as they had and will arrive to other business lines. The first is this migration from manual workflow to intelligent automation, where labor is geared for strategy advancements versus just status quo. The second is this conversion from desktop-based software to enterprise-deployed platforms which opens up to-be-discussed topics like content responsiveness, data self-servicing, and post-publication controls of content.?

?As a solution provider, we can?t build software in a vacuum. We actively go out and we engage clients and good organizations, like PAICR, to grow conversations, to learn from, and to share. Software may solve operational inefficiencies but they don?t necessarily direct and can?t force strategies. That?s left up to good people who shape their visions everyday to adapt and to negotiate against needs. So we thank PAICR members for allowing us to participate, to share our views, and to learn from you, who are daily practitioners and strategists. Exercises like this help propel our work in business systems like pitchbook software and client reporting software.? Perry Harris, Varden?s President, contributes.

Varden is a proud sponsor of PAICR, beginning in 2011 and renewed in 2012. PAICR?s upcoming events include the RFP Symposium, on May 21, and the Annual Conference, on September 10 ? 12.

Gail Prins-Visser, PAICR?s President, closes with, ?PAICR frequently uses Web-based events as we reach across borders to share industry movements and current practices. Marketing for financial services is an increasingly important industry role, and our purpose is to help our members learn, connect and succeed. We leverage this event with Varden Technologies as part of our continuous commitment to strengthen our members.?

About Varden Technologies, Inc.

Established in 1999, Varden Technologies is an investment data integration and technology firm. With the consulting line concentrating on data analysis, custom development, and OMS implementation, Varden?s product line serves the external investment communications niche. Its flagship platform, eReportal, drives responsive content strategies of investment marketing, sales, and client servicing teams with data-driven pitchbook software, performance and client reporting software, client servicing operational platforms, and custom deployments of point-of-entry data and content servicing portals. http://www.InvestmentCommunications.org

About PAICR

PAICR?s objective is to identify, interpret, guide and advocate the best practices in the investment communications industry. PAICR is dedicated to the professional development of communicators by providing each member with the necessary tools to provide solutions and help each individual excel at their profession. PAICR supports and nurtures a growing community of professionals who share insights through a multitude of innovative, interactive and educational forums. http://www.paicr.com

###

Varden Technologies, Inc. ????

211 Congress Street????

Boston, MA 02110????

http://www.VardenTech.com

Caitlin Hagaman, Marketing Manager????

617.482.5902 x322????

(caitlin(dot)hagaman(at)vardentech(dot)com)





Powered by WordPress | Designed by: best suv | Thanks to toyota suv, infiniti suv and lexus suv